Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (91-100 of 321) with videos related to

Pageof 33
Sort By:
Leukemia & Lymphoma|June 14, 2003
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximabRaymond Wong, Marcos de Lima, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2020
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2010
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantationStefan O Ciurea, Victor Mulanovich, Ying Jiang, et al.
European Journal of Haematology|August 22, 2003
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myelomaMaha Ahmed, Francis Giles, Youngson Joe, et al.
Cancer|April 29, 2017
Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemiaEric Segal, Michael Martens, Hai-Lin Wang, et al.
JCO Clinical Cancer Informatics|January 19, 2019
Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response RatesEhsan Malek, Caner Saygin, Rebecca Ye, et al.
Chemosphere|April 7, 2023
Co-exposure of iron oxide nanoparticles with glyphosate herbicides in Poecilia reticulata: Fish liver damages is reversible during iron accumulation and elimination periodJoão Marcos de Lima-Faria, Victória Costa da Silva, Lee Chen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research studyNelli Bejanyan, Daniel J Weisdorf, Brent R Logan, et al.
Chemosphere|June 12, 2021
Recovery trend to co-exposure of iron oxide nanoparticles (γ-Fe<sub>2</sub>O<sub>3</sub>) and glyphosate in liver tissue of the fish Poecilia reticulataJoão Marcos de Lima Faria, Lucas Nunes Guimarães, Victória Costa da Silva, et al.
Journal of Hematology & Oncology|October 16, 2020
Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemiaJorge E Cortes, Marcos de Lima, Hervé Dombret, et al.
Pageof 33

Showing results (91-100 of 321) with videos related to

Sort By:
Pageof 33
Leukemia & Lymphoma|June 14, 2003
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximabRaymond Wong, Marcos de Lima, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2020
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2010
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantationStefan O Ciurea, Victor Mulanovich, Ying Jiang, et al.
European Journal of Haematology|August 22, 2003
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myelomaMaha Ahmed, Francis Giles, Youngson Joe, et al.
Cancer|April 29, 2017
Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemiaEric Segal, Michael Martens, Hai-Lin Wang, et al.
JCO Clinical Cancer Informatics|January 19, 2019
Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response RatesEhsan Malek, Caner Saygin, Rebecca Ye, et al.
Chemosphere|April 7, 2023
Co-exposure of iron oxide nanoparticles with glyphosate herbicides in Poecilia reticulata: Fish liver damages is reversible during iron accumulation and elimination periodJoão Marcos de Lima-Faria, Victória Costa da Silva, Lee Chen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research studyNelli Bejanyan, Daniel J Weisdorf, Brent R Logan, et al.
Chemosphere|June 12, 2021
Recovery trend to co-exposure of iron oxide nanoparticles (γ-Fe<sub>2</sub>O<sub>3</sub>) and glyphosate in liver tissue of the fish Poecilia reticulataJoão Marcos de Lima Faria, Lucas Nunes Guimarães, Victória Costa da Silva, et al.
Journal of Hematology & Oncology|October 16, 2020
Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemiaJorge E Cortes, Marcos de Lima, Hervé Dombret, et al.
Pageof 33